Many liver cancer patients fail to receive the specific treatments recommended by multidisciplinary tumor boards due to breakdowns in the implementation phase. While clinical decisions are often sound, logistical gaps in scheduling procedures and imaging frequently delay or prevent the execution of the prescribed care plan.
The disconnect between high-level clinical recommendations and actual patient outcomes represents a critical failure point in hepatobiliary oncology. While tumor boards—groups of specialists who meet to discuss complex cases—provide a roadmap for treatment, the transition from a theoretical plan to a clinical reality is fraught with systemic hurdles. This issue was a central theme at The Liver Meeting 2026 in Denver, where experts highlighted that the primary obstacle is often not the medical decision itself, but the logistical coordination required to follow through.
How Tumor Board Recommendations Become Patient Care
- The Plan vs. The Reality: A tumor board’s suggestion is a professional recommendation, but it is not a binding order; the treating physician ultimately decides how to proceed.
- Implementation Gaps: Most treatment failures occur because of “falling through the cracks,” such as missed follow-up scans or scheduling delays, rather than incorrect medical advice.
- The Role of Navigators: A dedicated tumor board navigator is described as a critical piece—and the only sure solution—to ensure patients actually receive the complex series of treatments and tests they were promised.
Logistical Failures Undermine Multidisciplinary Liver Cancer Care
According to CancerNetwork, the gap in care is rarely a result of physicians ignoring tumor board advice. Instead, the breakdown occurs during the implementation phase. When a patient is recommended for a complex regimen involving multiple specialists, the sheer volume of required steps—such as coordinating PET scans, abdominal imaging, and specialized provider appointments—can lead to significant delays.
Gholam, who has led a tumor board for almost 15 to 16 years, noted that unless a dedicated navigator takes ownership of the plan, essential steps often fail to materialize. Without a central figure to manage the logistics, the patient may receive an incomplete version of the recommended care or face delays in receiving the full plan of care.
Global Disparities in Treatment Standards and Infrastructure
While the breakdown in care is often logistical, a broader gap exists between international clinical guidelines and real-world hospital capabilities. An international survey published in CVIR Oncology suggests that hospital infrastructure often dictates treatment more than established algorithms like the Barcelona Clinic Liver Cancer (BCLC) staging system.
The BCLC system is designed to guide everything from surveillance to transplantation based on tumor burden, liver function, and physical performance status. However, the survey revealed that approximately 36.25% of hospitals surveyed had no access to radioembolization, a specialized treatment option. This lack of access forces clinicians to depart from standard guidelines, regardless of what the staging system prescribes for the patient.
| Infrastructure Metric | Reported Percentage |
|---|---|
| Centers holding weekly multidisciplinary tumor boards | 72.5% |
| Centers networked with a transplant center | 77.5% |
| Hospitals lacking access to radioembolization | 36.25% |
Technological Inconsistencies in Thermal Ablation Practices
The survey also highlighted significant variations in how clinicians perform thermal ablation, a common curative option for smaller tumors. While microwave ablation has become the preferred method over radiofrequency ablation due to its ability to reach higher temperatures and mitigate “heat-sink effects”—where blood flow carries heat away from the tumor—the application of this technology is inconsistent.
Only about 36% of respondents systematically assessed the ablative margin, which is the rim of treated tissue surrounding the tumor. This margin is a vital predictor of whether the cancer will return locally. Furthermore, a quarter of respondents never used a multiprobe approach, and the same proportion performed ablations without any navigation system, suggesting that even when the correct technology is available, it is not being utilized uniformly to ensure complete tumor coverage.
How to Manage Treatment Delays and Logistical Gaps
If you have been recommended a specific treatment by a tumor board but find that your appointments, procedures, or imaging are being delayed, request the support of a tumor board navigator to help coordinate scheduling and ensure your care plan remains on track.
Closing the gap in liver cancer care requires a dual approach: improving the logistical infrastructure through dedicated patient coordinators and addressing the regional disparities in medical technology. While the clinical intelligence provided by tumor boards is increasingly sophisticated, the ultimate success of these interventions depends on the ability of the healthcare system to translate those recommendations into timely, standardized action.
References
- CancerNetwork (Source Transcript: Gholam PM, Ilyas SI, The Liver Meeting 2026)
- Bioengineer.org (Coverage of TTHM/MIO-Live 2024 Survey)
- Scienmag.com (Coverage of TTHM/MIO-Live 2024 Survey)
